News -

Maximising Drug Discovery Research- Interview with Attana CEO, Teodor Aastrup

"Drug discovery scientists should focus on the biological relevance of their candidate molecules as soon as possible in their research, to ensure a high probability of success in later stages”, says Teodor Aastrup, Chief Executive Officer and Founder of Attana AB. To maximise productivity, there is a need to understand reactions and interactions in the human body before research has advanced too much."

Click here to read the entire interview or access the pdf attached below.

Related links

Subjects

  • Medical research

Categories

  • drug discovery
  • attana
  • marcus evans
  • discovery summit 2011
  • biosensor
  • attana cell 200

Press contacts

Teodor Aastrup

Chief Executive Officer Chief Executive Officer

Related content

Related events